Background Maternal depression negatively impacts the health of both mothers and their children. Although several studies have reported on the prevalence of antenatal depression …
Summary On March 19, 2019, the United States Food and Drug Administration (FDA) approved Zulresso (brexanolone) for intravenous use for the treatment of postpartum …
Background: Stunting is caused by multi-dimensional factors and the most decisive intervention should be carried out in the first 1,000 days of life. Poor parenting practices, lack …
Abstract Background and Aims Bangladesh has made significant progress in declining maternal mortality in recent decades. However, the available evidence on the various …
F Al‐Mamun, MS Sultana, MA Momo… - Health Science …, 2024 - Wiley Online Library
Abstract Background and Aims Postpartum depression (PPD) is a globally recognized public health concern, yet research focusing on women in urban areas of Bangladesh remains …
S Güler, A Akcan - Perspectives in Psychiatric Care, 2021 - search.ebscohost.com
Purpose: This study evaluated the effect of the maternal risk of depression on the outcomes of infant care. Design and Methods: This study was conducted as a cross‐sectional and …
S Chhabria, H Kim, MS MAS, A Moreira, D Naamani… - scienceopen.com
Order of Authors: Elizabeth Carosella, MPH Shradha Chhabria, MD, MPH Hyelee Kim, MD, MAS, MS Aliya Moreira, MD, MPH Dana Naamani, MD, MPH Brennan Ninesling, MD, MPH …